HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumihiko Koiwa Selected Research

maxacalcitol

1/2020Early response of the parathyroid gland to withdrawal of a calcimimetic compound in uremic rats.
3/2017Research on kidney and mineral metabolism in Japan: past, present, and future.
5/2014Active vitamin D analogs, maxacalcitol and alfacalcidol, as maintenance therapy for mild secondary hyperparathyroidism in hemodialysis patients - a randomized study.
6/2007Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fumihiko Koiwa Research Topics

Disease

22Secondary Hyperparathyroidism
06/2022 - 09/2004
18Chronic Renal Insufficiency
04/2019 - 05/2007
7Hyperphosphatemia
01/2018 - 08/2005
6Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 12/2011
5Cardiovascular Diseases (Cardiovascular Disease)
02/2019 - 02/2005
5Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
03/2017 - 12/2007
4Hypercalcemia (Milk Alkali Syndrome)
10/2018 - 08/2006
4Vascular Calcification
03/2017 - 02/2005
4Hyperplasia
07/2010 - 06/2003
2Drug-Related Side Effects and Adverse Reactions
01/2022 - 11/2021
2Vasculitis (Vasculitides)
01/2021 - 05/2012
2Hyperparathyroidism
08/2019 - 08/2008
2Renal Insufficiency (Renal Failure)
08/2019 - 10/2014
2Proteinuria
07/2019 - 01/2015
2Anemia
02/2019 - 11/2018
2Diabetic Nephropathies (Diabetic Nephropathy)
02/2019 - 12/2014
2Cardiomegaly (Heart Hypertrophy)
01/2019 - 01/2011
2Inflammation (Inflammations)
11/2018 - 05/2012
2Kidney Diseases (Kidney Disease)
10/2018 - 06/2013
2IGA Glomerulonephritis (IGA Nephropathy)
01/2015 - 06/2006
2Neoplasms (Cancer)
05/2012 - 06/2006
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
06/2022
1Nephritis
04/2022
1Pyoderma Gangrenosum
01/2021
1Arthritis (Polyarthritis)
01/2021
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2021
1Hidradenitis Suppurativa
01/2021
1Colitis
01/2021
1Acne Vulgaris
01/2021
1Disseminated Intravascular Coagulation
07/2019
1Abdominal Pain (Pain, Abdominal)
07/2019
1Edema (Dropsy)
07/2019
1Thrombocytopenia (Thrombopenia)
07/2019
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
07/2019
1Nephrotic Syndrome (Syndrome, Nephrotic)
07/2019
1Acidosis
02/2019
1Albuminuria
02/2019
1Diabetes Mellitus
02/2019
1Hypoxia (Hypoxemia)
11/2018
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2018
1Duane Retraction Syndrome (Duane Syndrome)
01/2018
1Nausea
10/2017
1Uremia
10/2016
1Myocardial Ischemia (Ischemic Heart Diseases)
12/2015
1Heart Failure
12/2015
1Hematuria
01/2015

Drug/Important Bio-Agent (IBA)

11Phosphates (Orthophosphate)IBA
11/2021 - 08/2006
11MineralsIBA
08/2019 - 05/2007
9Parathyroid Hormone (Parathormone)IBA
06/2022 - 08/2006
8CalciumIBA
11/2021 - 02/2005
8Vitamin DFDA LinkGeneric
08/2019 - 09/2004
7Cinacalcet (Sensipar)FDA Link
11/2021 - 08/2006
6Ethanol (Ethyl Alcohol)IBA
08/2008 - 06/2003
4maxacalcitolIBA
01/2020 - 06/2007
4Calcitriol Receptors (Calcitriol Receptor)IBA
01/2020 - 05/2012
4Phosphorus (Red Phosphorus)IBA
08/2019 - 02/2005
4IronIBA
04/2019 - 06/2017
3Sevelamer (RenaGel)FDA Link
01/2018 - 02/2005
3Calcium Carbonate (Limestone)FDA Link
01/2018 - 08/2005
3sucroferric oxyhydroxideIBA
01/2018 - 01/2017
2upacicalcetIBA
06/2022 - 01/2022
2evocalcetIBA
11/2021 - 11/2021
2calcium phosphateIBA
11/2021 - 07/2009
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2021 - 01/2021
2Ferritins (Ferritin)IBA
04/2019 - 01/2019
2AlbuminsIBA
02/2019 - 10/2018
2Angiotensin Receptor AntagonistsIBA
02/2019 - 12/2015
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2019 - 01/2011
2Hemoglobins (Hemoglobin)IBA
02/2019 - 12/2014
2Serum AlbuminIBA
02/2019 - 02/2019
2ErythropoietinFDA Link
11/2018 - 05/2012
2Calcitriol (Calcijex)FDA LinkGeneric
03/2017 - 06/2007
1SodiumIBA
06/2022
1Immunoglobulin A (IgA)IBA
04/2022
1AntibodiesIBA
01/2021
1Peroxidase (Myeloperoxidase)IBA
01/2021
1Anticardiolipin AntibodiesIBA
01/2021
1Serine Proteases (Serine Protease)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Rituximab (Mabthera)FDA Link
07/2019
1Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
02/2019
1Bicarbonates (Hydrogen Carbonate)IBA
02/2019
1CreatinineIBA
02/2019
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
11/2018
1MafB Transcription FactorIBA
01/2018
1bixalomerIBA
03/2017
126,26,26,27,27,27- hexafluoro- 1,25- dihydroxyvitamin D3IBA
03/2017
1Propylene Glycol (1,2 Propanediol)FDA LinkGeneric
10/2016
1paricalcitol (Zemplar)FDA Link
10/2016
15- (2- (1- (1- (3- hydroxy- 2,3- dimethylbutoxy)ethyl)- 7alpha- methyldihydro- 1H- inden- 4(2H,5H,6H,7H,7alphaH)- ylidene)ethylidene)- 2- methylenecyclohexane- 1,3- diolIBA
10/2016
1iodofiltic acidIBA
12/2015
1AcidsIBA
12/2015
1SteroidsIBA
01/2015
1MagnesiumIBA
10/2014
1alfacalcidolIBA
05/2014

Therapy/Procedure

18Renal Dialysis (Hemodialysis)
01/2022 - 02/2005
14Therapeutics
01/2018 - 06/2003
3Parathyroidectomy
08/2008 - 09/2004
1Intravenous Administration
01/2022
1Tonsillectomy
01/2015